FUNCTION OF SGS1, A HOMOLOG OF BLM AND WRN
SGS1 的功能,BLM 和 WRN 的同源物
基本信息
- 批准号:6019272
- 负责人:
- 金额:$ 25.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-30 至 2001-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The specific aim of this proposal is to study the function of Sgs1.
This gene was first isolated as a slow growth suppressor of top3
mutants in Saccharomyces cerevisiae and found to be homologous to
the E. coli RecQ helicase. Cells with Sgs1 mutations exhibit hyper-
recombination between repeated sequences, show increased
chromosome non-disjunction and sporulate poorly as homozygous
diploids. Recently, the genes responsible for two human diseases,
Bloom and Werner syndromes were cloned and found to be
homologous with Sgs1. Thus, the study of Sgs1 in yeast may provide
insights into the function of the members of this multigene family and
may yield important clues to the etiology of cancer in these two
syndromes. The specific approaches are: the PI will investigate both
the physical and genetic interactions between Sgs1, topoisomerases,
checkpoint genes and other yeast genes including helicases. He will
develop a novel allele replacement technique to aid in the study of
these interactions. (2) He will investigate the relationship between
Sgs1 and its human counterparts by cross-complementation studies in
both yeast and mammalian cells.
Specifically, he will swap domains among these genes to define the
units necessary for function. In addition, he will determine if the
same physical interactions that occur in yeast can occur in mammalian
cells. Furthermore, sensitivity to various inhibitors will be tested to
characterized the human homologs. (3) The investigator will purify
both Sgs1 and the components with which it interacts in order to
define their biochemical function(s). In addition, DNA topology of
both native sequences and introduced plasmids will be investigated by
varying the gene dosage of Sgs1 and its interacting components. (4)
He will determine the parameters that affect hyper-recombination
between repeated sequences resulting from a Sgs1 deficiency.
Specifically, he will examine sequences from two locations that exhibit
hyper-recombination in the absence of Sgs1 -- the rDNA array and the
SUP4 region. The PI will also investigate the relationship between
replication fork pausing and hyper-recombination.
本提案的具体目的是研究Sgs1的功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rodney J. ROTHSTEIN其他文献
Rodney J. ROTHSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rodney J. ROTHSTEIN', 18)}}的其他基金
Molecular Mechanisms Underlying Recombination at DNA Double-Strand Breaks and Stalled Replication Forks
DNA 双链断裂和停滞复制叉重组的分子机制
- 批准号:
10582329 - 财政年份:2021
- 资助金额:
$ 25.89万 - 项目类别:
Molecular Mechanisms Underlying Recombination at DNA Double-Strand Breaks and Stalled Replication Forks
DNA 双链断裂和停滞复制叉重组的分子机制
- 批准号:
10459423 - 财政年份:2016
- 资助金额:
$ 25.89万 - 项目类别:
Molecular Mechanisms Underlying Recombination at DNA Double-Strand Breaks and Stalled Replication Forks
DNA 双链断裂和停滞复制叉重组的分子机制
- 批准号:
10207088 - 财政年份:2016
- 资助金额:
$ 25.89万 - 项目类别:
Molecular Mechanisms Underlying DNA Double-Strand Break and Crosslink Repair
DNA 双链断裂和交联修复的分子机制
- 批准号:
9071797 - 财政年份:2016
- 资助金额:
$ 25.89万 - 项目类别:
Molecular Mechanisms Underlying DNA Double-Strand Break and Crosslink Repair
DNA 双链断裂和交联修复的分子机制
- 批准号:
9343027 - 财政年份:2016
- 资助金额:
$ 25.89万 - 项目类别:
Molecular Mechanisms Underlying Recombination at DNA Double-Strand Breaks and Stalled Replication Forks
DNA 双链断裂和停滞复制叉重组的分子机制
- 批准号:
10670267 - 财政年份:2016
- 资助金额:
$ 25.89万 - 项目类别:
Using synthetic dosage lethality to screen for novel anti-tumor targets
利用合成剂量致死率筛选新型抗肿瘤靶点
- 批准号:
7193746 - 财政年份:2007
- 资助金额:
$ 25.89万 - 项目类别:
Using synthetic dosage lethality to screen for novel anti-tumor targets
利用合成剂量致死率筛选新型抗肿瘤靶点
- 批准号:
7599616 - 财政年份:2007
- 资助金额:
$ 25.89万 - 项目类别:
Using synthetic dosage lethality to screen for novel anti-tumor targets
利用合成剂量致死率筛选新型抗肿瘤靶点
- 批准号:
7414719 - 财政年份:2007
- 资助金额:
$ 25.89万 - 项目类别:
Yeast Chromosome Structure, Replication and Segregation
酵母染色体结构、复制和分离
- 批准号:
7439225 - 财政年份:2006
- 资助金额:
$ 25.89万 - 项目类别:
相似海外基金
Elucidation of the life-sustaining mechanism of hyperthermophilic archaea without DNA replication origin
阐明无DNA复制起点的超嗜热古菌的生命维持机制
- 批准号:
19K22289 - 财政年份:2019
- 资助金额:
$ 25.89万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Identification of the DNA replication origin in Arabidopsis
拟南芥DNA复制起点的鉴定
- 批准号:
17K19250 - 财政年份:2017
- 资助金额:
$ 25.89万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Genome-wide identification of DNA replication origin sequences in human cells
人类细胞 DNA 复制起点序列的全基因组鉴定
- 批准号:
16K12595 - 财政年份:2016
- 资助金额:
$ 25.89万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
- 批准号:
8457662 - 财政年份:2013
- 资助金额:
$ 25.89万 - 项目类别:
Integrating stress MAP kinase signaling with DNA replication origin licensing
将应激 MAP 激酶信号传导与 DNA 复制起点许可相结合
- 批准号:
8706908 - 财政年份:2013
- 资助金额:
$ 25.89万 - 项目类别:
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
- 批准号:
8665806 - 财政年份:2013
- 资助金额:
$ 25.89万 - 项目类别:
Integrating stress MAP kinase signaling with DNA replication origin licensing
将应激 MAP 激酶信号传导与 DNA 复制起点许可相结合
- 批准号:
8824650 - 财政年份:2013
- 资助金额:
$ 25.89万 - 项目类别:
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
- 批准号:
8829782 - 财政年份:2013
- 资助金额:
$ 25.89万 - 项目类别:
Post-translational regulation of DNA replication origin licensing in human cells
人类细胞 DNA 复制起点许可的翻译后调控
- 批准号:
10093060 - 财政年份:2013
- 资助金额:
$ 25.89万 - 项目类别:
Diversity Supplement: Post-Translational Regulation of DNA Replication Origin Licensing in Human Cells
多样性补充:人类细胞中 DNA 复制起点许可的翻译后调控
- 批准号:
10120875 - 财政年份:2013
- 资助金额:
$ 25.89万 - 项目类别:














{{item.name}}会员




